How is the Blood Screening Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the blood screening market grown in recent years?
The market capacity of blood screening has seen significant growth over recent times. Anticipated to grow from a size of $3.15 billion in 2024 to $3.45 billion in 2025, it boasts a compound annual growth rate (CAGR) of 9.6%. The growth experienced during the historic period is attributable to factors including the heightened need for blood transfusions, surge in transmissible diseases, government norms and standards, rise in blood donations and collections, and global health crises and pandemics.
How is the blood screening market size expected to evolve during the forecast period?
The market size of blood screening is anticipated to experience swift growth in the upcoming years, reaching a value of $5.37 billion in 2029 with a compound annual growth rate (CAGR) of 11.7%. This projected growth during the forecast period can be ascribed to factors such as advancements in healthcare infrastructures, public health consciousness initiatives, progress in diagnosing infectious diseases, concerns about global health, and readiness for potential pandemics. The forecast period is expected to witness key trends such as an increase in infectious diseases, efficiency and automation, an upsurge in the demand for blood transfusion, a concentration on the safety of transfusion, and a surge in research for pathogen detection.
Get your blood screening market report here!
https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report
Which key drivers are propelling the blood screening market’s growth?
The escalation in the incidence of contagious diseases is predicted to boost the expansion of the blood screening market in the future. Blood examination is typically done to detect signs of ailments by identifying a particular antibody produced against the pathogenic carrier. This assists healthcare professionals in managing infectious diseases and stopping further spread of infections among patients and direct transmissions. For example, in June 2022, as per the data from the National Center for Biotechnology Information, a government agency in the United States, there has been almost a threefold rise in the incidence of infectious diseases in outpatient healthcare over twenty years, going up from 8 to 26 per 1,000. As a result, the escalation in contagious disease incidence is propelling the rise of the blood screening market.
What are the market segments in the blood screening industry?
The blood screening market covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments, Software And Services
2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)
3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)
Subsegments:
1) By Reagents And Kits: Diagnostic Reagents, Testing Kits
2) By Instruments: Automated Analyzers, Manual Testing Equipment
3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp
Which leading companies are shaping the growth of the blood screening market?
Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.
What key trends are currently impacting the blood screening market’s development?
Leading entities within the blood screening market are introducing innovation like liquid biopsy, aiming to improve early identification of cancer, refine treatment monitoring, and facilitate personalized medical protocols. Liquid biopsy is a less intrusive procedure that enables examination of blood or body fluids to trace cancer cells or tumor-related genetic material. For example, in November 2023, Shield blood-based screening tests were introduced by Guardant Health, Inc., a biotech company based in the US. This Shield test examines cell-free DNA (cfDNA) circulating in the bloodstream, which may signal the existence of colorectal tumors or precancerous developments—it specifically identifies changes in DNA fragments that have been released into the blood by cancer cells.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9047
Which geographic areas are influencing the growth of the blood screening market?
North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Analytical Laboratory Instrument Global Market Report 2024
Blood And Blood Components Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report
Blood Group Typing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
